[EN] NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS [FR] NOUVEAUX DÉRIVÉS D'ARYLALCÈNE ET UTILISATION DE CEUX-CI EN TANT QUE MODULATEURS SÉLECTIFS DE RÉCEPTEUR D'OESTROGÈNE
NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS
申请人:Centaurus BioPharma Co., Ltd.
公开号:US20150018341A1
公开(公告)日:2015-01-15
The invention provides novel ethylene derivatives represented by Formula I, which may be used as selective estrogen receptor modulators (SERMs) and useful in the prophylaxis and/or treatment of estrogen-dependent conditions or conditions.
Arylalkene derivatives and use thereof as selective estrogen receptor modulators
申请人:Centaurus BioPharma Co., Ltd.
公开号:US09309211B2
公开(公告)日:2016-04-12
The invention provides novel ethylene derivatives represented by Formula I, which may be used as selective estrogen receptor modulators (SERMs) and useful in the prophylaxis and/or treatment of estrogen-dependent conditions or conditions.
Organocatalyzed Double C(sp<sup>3</sup>)−H Alkylation of Cyclic <i>N</i>‐Sulfonyl Ketimines with 3‐Chloropropiophenones: Selective Access to 2,3,6‐Trisubstituted Pyridines
作者:Ashvani Kumar Patel、Sampak Samanta
DOI:10.1002/ejoc.202300631
日期:2023.9
Efficient de novo access to 2,3,6-trisubstituted pyridines was successfully synthesized through a mono- or dialkylation reaction between 4/3-alkyl-N-sulfonyl ketimines with 3-chloropropiophenones using DIPEA/NaHCO3 as a cheap cooperative basic system and subsequent aza-cyclization in the presence of NH4OAc under an air.
Nucleophilic Cyanation of Enones and Imines with Formamide as the Cyano Source
作者:Lei Luo、Hong Dai、Ming‐Qing Yang、Luo Yang
DOI:10.1002/adsc.202400482
日期:——
Conflict of Interests The authors declare no competing financial interest.
利益冲突 作者声明不存在竞争性经济利益。
Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors
作者:Yong-Yong Zheng、Lin Guo、Xue-Chu Zhen、Jian-Qi Li
DOI:10.1016/j.ejmech.2012.04.030
日期:2012.8
A series of arylalkanol-piperidine derivatives was synthesized, and their triple reuptake inhibition and in vivo activities have been evaluated. Among them, compounds 2a, 2j, 2k, 2m and 2n exhibited high potency for 5-HT, NA and DA transporters. Optimized compounds 2j and 2m showed significant reduction of immobility time compared to that of vehicle in the mouse tail suspension test (TST) test at doses ranging from 10 to 50 mg/kg po, and were not generally motor stimulants at 50 mg/kg dose. In addition, compounds 2j and 2m displayed desirable pharmacokinetic properties in SD rats. (C) 2012 Elsevier Masson SAS. All rights reserved.